ORIC Pharmaceuticals, Inc. (ORIC)
NASDAQ: ORIC · Real-Time Price · USD
13.74
-0.17 (-1.22%)
Aug 27, 2026, 4:00 PM EDT - Market closed
ORIC Pharmaceuticals Market Cap
ORIC Pharmaceuticals has a market cap or net worth of $1.42 billion as of August 28, 2026. Its market cap has increased by 48.87% in one year.
Market Cap
1.42B
Enterprise Value
1.17B
1-Year Change
48.87%
Ranking
Category
Stock Price
$13.74
ChartMarket Cap Chart
Since April 24, 2020, ORIC Pharmaceuticals's market cap has increased from $741.98M to $1.42B, an increase of 91.94%. That is a compound annual growth rate of 10.82%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2026 | 1.42B | 78.77% |
| Dec 31, 2025 | 796.64M | 39.89% |
| Dec 31, 2024 | 569.48M | 13.47% |
| Dec 29, 2023 | 501.88M | 89.55% |
| Dec 30, 2022 | 264.77M | -54.26% |
| Dec 31, 2021 | 578.91M | -53.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SL Science Holding | 1.51B |
| Replimune Group | 1.49B |
| Aktis Oncology | 1.48B |
| Cullinan Therapeutics | 1.48B |
| MeiraGTx Holdings | 1.43B |
| Latigo Biotherapeutics | 1.43B |
| Alto Neuroscience | 1.42B |
| Savara | 1.42B |